BMO Capital reiterates Outperform on Constellation Brands at $190

0 min read | Published on 25 Jun 2026, 09:04 PM |Updated on 03 Jul 2026, 12:30 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

BMO Capital analyst Andrew Strelzik has reiterated an Outperform rating on Constellation Brands (NYSE: STZ) and maintained a price target of $190, reflecting confidence in the company's market performance and valuation potential.

*this image is generated using AI for illustrative purposes only.

BMO Capital analyst Andrew Strelzik has reiterated an Outperform rating on Constellation Brands (NYSE: STZ) and maintained a price target of $190. This endorsement underscores confidence in the company's market performance and valuation potential. The rating suggests that the stock is expected to outperform broader market indices.

Analyst Ratings

The following table summarizes the current analyst stance:

Metric	Value
Rating	Outperform
Price Target	$190

Constellation Brands continues to be monitored for its operational efficiency and market position. The maintained price target reflects a steady outlook on the company's financial health and strategic direction.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational efficiency improvements are expected to drive Constellation Brands' stock performance?

How might changes in consumer preferences impact Constellation Brands' market position and valuation?

What are the potential risks or challenges that could prevent the stock from reaching the $190 price target?

Roth Capital reiterates Buy on Constellation Brands, maintains $209 target

0 min read | Published on 02 Jul 2026, 10:02 PM |Updated on 03 Jul 2026, 12:29 AM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

Roth Capital analyst Bill Kirk has reiterated a Buy rating on Constellation Brands (NYSE: STZ) with a maintained price target of $209. This positive outlook contrasts with a recent Underperform rating from B of A Securities, which set a $145 target, highlighting differing analyst views on the stock's potential.

*this image is generated using AI for illustrative purposes only.

Roth Capital analyst Bill Kirk has reiterated a Buy rating on Constellation Brands (NYSE: STZ) and maintained a price target of $209. This endorsement contrasts with recent bearish sentiment from other firms, highlighting a divergence in analyst perspectives on the beverage alcohol company's near-term trajectory.

The $209 price target suggests potential upside from current levels, as Kirk remains confident in the company's fundamental strengths and market position. This stance provides an alternative view for investors assessing the stock's valuation against broader industry trends.

Analyst Ratings and Price Targets

Firm	Analyst	Rating	Price Target
Roth Capital	Bill Kirk	Buy	$209
B of A Securities	Peter Galbo	Underperform	$145

The table above illustrates the varying opinions on Constellation Brands. While B of A Securities lowered its target to $145 citing valuation concerns, Roth Capital maintains a more optimistic outlook with its $209 target and Buy rating.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What upcoming earnings report or product launch could serve as the next major catalyst for the stock?

How might Constellation Brands' performance in the beer versus spirits segments influence future analyst ratings?

What impact could macroeconomic factors like inflation or changing consumer spending habits have on the company's near-term growth?